Search form

Blood screening

The Grifols Procleix assays, developed as part of our long-standing partnership with Grifols and manufactured by Hologic, have significantly increased the safety of the world's supply of donated blood and plasma by directly detecting the genetic material of viruses such as HIV-1 and hepatitis C. The Grifols Procleix products used in conjunction with other screening techniques, public health policies, and other strategies, have helped to reduce the risk of contracting these dangerous diseases from a blood transfusion in the U.S. to approximately 1 in 2,000,000. The Grifols Procleix assays are built on innovative amplification and detection technologies developed by Hologic, including target capture and transcription-mediated amplification (TMA).